By Liz McKenzie ( April 17, 2009, 12:00 AM EDT) -- A Merck & Co. unit and Teva Pharmaceuticals USA Inc. have lodged a consent decree in Merck's third suit over a patent for blockbuster allergy and asthma drug Singulair, agreeing to resolve the spat based on the outcome of a pending suit between the two parties over the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.